NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics [Yahoo! Finance]
Bluejay Diagnostics, Inc. (BJDX)
Company Research
Source: Yahoo! Finance
Inc., today issued an open letter to the Board of Directors and shareholders of Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”) recommending the Board evaluate a strategic opportunity that NorthStrive believes could significantly enhance long-term shareholder value. NorthStrive Fund is a significant shareholder of Bluejay and previously disclosed its ownership in a Schedule 13G filed with the U.S. Securities and Exchange Commission on February 5, 2026. In the letter, NorthStrive Fund expressed support for the Board and management team's continued progress advancing the Company's current core program, SYMON™ II, while encouraging the Company to strengthen its strategic positioning through pipeline expansion capable of introducing additional clinical milestones and value-inflection points. The letter recommends that the Board review the potential acquisition of a Phase-1-ready therapeutic asset targeting refractory chronic cough, a condition affecting millions of patients g
Show less
Read more
Impact Snapshot
Event Time:
BJDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BJDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BJDX alerts
High impacting Bluejay Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
BJDX
News
- Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual MeetingGlobeNewswire
- Bluejay Diagnostics Provides Corporate Update and 2026 Strategic OutlookGlobeNewswire
- Bluejay Diagnostics Announces All Prefunded Warrants Now ExercisedGlobeNewswire
- Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026GlobeNewswire
BJDX
Sec Filings
- 3/17/26 - Form 8-K
- 3/16/26 - Form 8-K
- 3/12/26 - Form 8-K
- BJDX's page on the SEC website